Stocks · Health care · Pharmaceutical Preparations

PRECIGEN, INC.

PGEN Clue Score15
United States Fiscal year ends December CIK 0001356090
$7.81 +2.76% Close, 9 Oct 2026
Price $7.81 +69.41% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue190.9Operating income−125.2Net income−186.6Fiscal year 2017Revenue219.5 +14.9%Operating income−137.9Net income−117.0Fiscal year 2018Revenue151.2 −31.1%Operating income−505.6Net income−509.3Fiscal year 2019Revenue90.7 −40.0%Net income−322.3EPS, diluted−2.09Fiscal year 2020Revenue32.0 −64.7%Net income−170.5EPS, diluted−1.02Fiscal year 2021Revenue14.3 −55.4%Net income−92.2EPS, diluted−0.47Fiscal year 2022Revenue26.9 +88.6%Net income28.3EPS, diluted0.14Fiscal year 2023Revenue6.2 −76.9%Operating income−99.8Net income−95.9 −438.7%EPS, diluted−0.39 −378.6%Fiscal year 2024Revenue3.9 −36.9%Operating income−135.0Net income−126.2EPS, diluted−0.47Fiscal year 2025Revenue9.7 +146.7%Operating income−110.5Net income−250.6EPS, diluted−1.37
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 190.9 219.5 151.2 90.7 32.0 14.3 26.9 6.2 3.9 9.7
Growth +14.9% −31.1% −40.0% −64.7% −55.4% +88.6% −76.9% −36.9% +146.7%
Operating income −125.2 −137.9 −505.6 n/a n/a n/a n/a −99.8 −135.0 −110.5
Net income −186.6 −117.0 −509.3 −322.3 −170.5 −92.2 28.3 −95.9 −126.2 −250.6
Growth −438.7%
EPS, diluted n/a n/a n/a −2.09 −1.02 −0.47 0.14 −0.39 −0.47 −1.37
Growth −378.6%

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2016Operating margin−65.6%Net margin−97.7%Free cash flow margin−42.2%Fiscal year 2017Operating margin−62.8%Net margin−53.3%Free cash flow margin−68.5%Fiscal year 2018Operating margin−334.4%Net margin−336.9%Free cash flow margin−109.7%Fiscal year 2019Net margin−355.3%Free cash flow margin−191.6%Fiscal year 2020Net margin−533.0%Free cash flow margin−264.3%Fiscal year 2021Net margin−646.0%Free cash flow margin−441.7%Fiscal year 2022Net margin105.2%Free cash flow margin−260.0%Fiscal year 2023Operating margin−1,602.5%Net margin−1,540.6%Free cash flow margin−1,099.9%Fiscal year 2024Operating margin−3,440.2%Net margin−3,216.2%Free cash flow margin−1,955.6%Fiscal year 2025Operating margin−1,141.1%Net margin−2,588.2%Free cash flow margin−927.6%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin −65.6% −62.8% −334.4% n/a n/a n/a n/a −1,602.5% −3,440.2% −1,141.1%
Net margin −97.7% −53.3% −336.9% −355.3% −533.0% −646.0% 105.2% −1,540.6% −3,216.2% −2,588.2%
Free cash flow margin −42.2% −68.5% −109.7% −191.6% −264.3% −441.7% −260.0% −1,099.9% −1,955.6% −927.6%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−49.0Capital expenditure−31.6Free cash flow−80.6Fiscal year 2017Operating cash flow−103.7Capital expenditure−46.7Free cash flow−150.4Fiscal year 2018Operating cash flow−124.2Capital expenditure−41.6Free cash flow−165.8Fiscal year 2019Operating cash flow−135.9Capital expenditure−37.9Free cash flow−173.8Fiscal year 2020Operating cash flow−77.0Capital expenditure−7.5Free cash flow−84.5Fiscal year 2021Operating cash flow−55.8Capital expenditure−7.2Free cash flow−63.0Fiscal year 2022Operating cash flow−65.0Capital expenditure−4.9Free cash flow−70.0Fiscal year 2023Operating cash flow−66.9Capital expenditure−1.5Free cash flow−68.5Fiscal year 2024Operating cash flow−68.2Capital expenditure−8.6Free cash flow−76.8Fiscal year 2025Operating cash flow−87.8Capital expenditure−2.0Free cash flow−89.8
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −49.0 −103.7 −124.2 −135.9 −77.0 −55.8 −65.0 −66.9 −68.2 −87.8
Capital expenditure −31.6 −46.7 −41.6 −37.9 −7.5 −7.2 −4.9 −1.5 −8.6 −2.0
Free cash flow −80.6 −150.4 −165.8 −173.8 −84.5 −63.0 −70.0 −68.5 −76.8 −89.8
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash62.6Total debt7.9Net cash (debt)54.7Shareholders’ equity560.2Debt to equity0.01Fiscal year 2017Cash68.1Total debt8.0Net cash (debt)60.1Shareholders’ equity533.6Debt to equity0.02Fiscal year 2018Cash96.9Total debt211.7Net cash (debt)−114.8Shareholders’ equity362.9Debt to equity0.58Fiscal year 2019Cash65.8Total debt218.0Net cash (debt)−152.2Shareholders’ equity71.7Debt to equity3.04Fiscal year 2020Cash51.8Total debt171.9Net cash (debt)−120.1Shareholders’ equity67.2Debt to equity2.56Fiscal year 2021Cash36.4Total debt179.9Net cash (debt)−143.5Shareholders’ equity107.3Debt to equity1.68Fiscal year 2022Cash4.9Total debt43.2Net cash (debt)−38.4Shareholders’ equity126.3Debt to equity0.34Fiscal year 2023Cash7.6Shareholders’ equity118.5Fiscal year 2024Cash29.5Total debt0.0Net cash (debt)29.5Shareholders’ equity38.5Debt to equity0.00Fiscal year 2025Cash30.2Total debt93.2Net cash (debt)−62.9Shareholders’ equity20.9Debt to equity4.46
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 62.6 68.1 96.9 65.8 51.8 36.4 4.9 7.6 29.5 30.2
Total debt 7.9 8.0 211.7 218.0 171.9 179.9 43.2 n/a 0.0 93.2
Net cash (debt) 54.7 60.1 −114.8 −152.2 −120.1 −143.5 −38.4 n/a 29.5 −62.9
Shareholders’ equity 560.2 533.6 362.9 71.7 67.2 107.3 126.3 118.5 38.5 20.9
Debt to equity 0.01 0.02 0.58 3.04 2.56 1.68 0.34 n/a 0.00 4.46

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
190.9 219.5 151.2 90.7 32.0 14.3 26.9 6.2 3.9 9.7
Growth +14.9% −31.1% −40.0% −64.7% −55.4% +88.6% −76.9% −36.9% +146.7%
112.1 143.2 404.6 n/a n/a n/a n/a 48.6 53.1 41.3
142.3 146.1 137.8 n/a n/a n/a n/a 40.4 41.3 70.1
−125.2 −137.9 −505.6 n/a n/a n/a n/a −99.8 −135.0 −110.5
Growth
−194.2 −78.4 −395.9 −171.3 −104.5 −111.0 −80.0 −96.4 −128.0 −250.6
−3.9 2.1 −15.4 −0.9 −0.1 −0.2 −0.2 −0.5 −1.8 0.0
−186.6 −117.0 −509.3 −322.3 −170.5 −92.2 28.3 −95.9 −126.2 −250.6
Growth −438.7%
Per share
n/a n/a n/a −2.09 −1.02 −0.47 0.14 −0.39 −0.47 −1.37
n/a n/a n/a −2.09 −1.02 −0.47 0.14 −0.39 −0.47 −1.37
Growth −378.6%
n/a n/a n/a 154.1 167.1 197.8 200.4 244.5 267.7 313.0
n/a n/a n/a 154.1 167.1 197.8 200.4 244.5 267.7 313.0
Growth +8.4% +18.4% +1.3% +22.0% +9.5% +16.9%

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue shrank 21.3% a year over five years.
  • The diluted share count rose 87.3% in five years, which is dilution.
  • A net loss in 9 of 10 years on file.